Correlation Between Oncolytics Biotech and Seres Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Seres Therapeutics, you can compare the effects of market volatilities on Oncolytics Biotech and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Seres Therapeutics.

Diversification Opportunities for Oncolytics Biotech and Seres Therapeutics

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Oncolytics and Seres is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Seres Therapeutics go up and down completely randomly.

Pair Corralation between Oncolytics Biotech and Seres Therapeutics

Given the investment horizon of 90 days Oncolytics Biotech is expected to generate 1.12 times more return on investment than Seres Therapeutics. However, Oncolytics Biotech is 1.12 times more volatile than Seres Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Seres Therapeutics is currently generating about -0.21 per unit of risk. If you would invest  89.00  in Oncolytics Biotech on October 20, 2024 and sell it today you would lose (10.00) from holding Oncolytics Biotech or give up 11.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Oncolytics Biotech  vs.  Seres Therapeutics

 Performance 
       Timeline  
Oncolytics Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Seres Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Seres Therapeutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Oncolytics Biotech and Seres Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncolytics Biotech and Seres Therapeutics

The main advantage of trading using opposite Oncolytics Biotech and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.
The idea behind Oncolytics Biotech and Seres Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Transaction History
View history of all your transactions and understand their impact on performance